MiƱao, Mia .
HRN: 26-06-09 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/15/2025
10/21/2025
IV
300mg
Q6
PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes